Pharmacodynamic and pharmacokinetic evaluation Of verbenone in normal and ovalbumin induced Asthmatic rats
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Verbenone is a naturally occurring anti-aggregation pheromone generated by bark
newlinebeetles from a host tree resin precursor, and#61537;-pinene. Asthma is a common chronic disorder of
newlinethe airways that is complex and characterized by variable and recurring symptoms, airflow
newlineobstruction, bronchial hyper-responsiveness, and an underlying inflammation. In the current
newlinestudy, the acute toxicity at the rate of 2000 mg/kg body weight single oral dosing, sub acute
newlinetoxicity at the rate of 200 mg/kg oral dosing for 30days, pharmacokinetics of verbenone in
newlinenormal healthy as well as ovalbumin-induced asthmatic animals and pharmacodynamic
newlineactivity of verbenone in healthy and asthmatic animals were done. It was found that the
newlineverbenone did not produce any toxicity at the dose rate of 2000 mg/kg single oral dose
newlinemaking it a practically non toxic compound. Besides, repeated dose administration for 30
newlinedays at the dose rate of 200 mg/kg orally also did not produce any appreciable toxicity. It was
newlinealso found that the drug did not produce any central nervous system effects as evidenced by
newlinelack of variation in spontaneous locomotor activity.
newlineIn single dose non-compartmental pharmacokinetics in rats, it was found that the
newlinemean terminal elimination rate constant was 0.133±0.030/ h, mean elimination t1/2 of
newline4.368±0.888 hours, observed mean AUC0-inf was 1.361 ± 0.0520 and#956;g/ml*h, observed AUMC0-
newlineinf was 6.441± 0.6356 and#956;g/ml*h2, mean residence time was 6.304± 0.385 hours, Cmax and Tmax
newlinewere 0.497±0.049 and#956;g/ml and h hour, respectively. Apparent volume of distribution during
newlineterminal phase was 1134.798± 161.65 (mg)/(and#956;g/ml) and apparent total body clearance of the
newlinedrug from plasma was 147.1769±5.645 (mg)/(and#956;g/ml)/h. Comparing the pharmacokinetics in
newlinenormal and asthmatic animals it was found that though the Tmax did not change in disease
newlinecondition all other parameters were significantly altered. In asthmatic animals maximum
newlineplasma concentration changed from 0.497 ± 0.049 to 0.322 ± 0.015 and#956;g/ml. The AUC0-inf had
newlinereduced from 1.361 ± 0.052 to 0.828 ± 0.012 and#956;g/ml*h